Intrinsic Value of S&P & Nasdaq Contact Us

The Valens Company Inc. VLNS.TO TSX

Toronto Stock Exchan • Healthcare • Drug Manufacturers - Specialty & Generic • CA • CAD

SharesGrow Score
30/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — VLNS.TO

The Valens Company Inc. (VLNS.TO) and trades at $1.01. The 52-week range is 0.76-3.79.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.9, Earnings Per Share (EPS) of $-1.15, annual revenue of $78.18M.

The stock has a beta of 0.00, operates in the Healthcare sector.

Trading Data
Current Price$1.01
52-Week Range0.76-3.79
Volume57.43K
Avg Volume (30D)130.04K
Beta (1Y)0.00
Company
IPO Date2020-04-16
Employees445
CEOJeffrey Fallows CFA
CountryCA
ExchangeToronto Stock Exchan
CurrencyCAD
ISINCA91914P6030
CUSIP91914P603
Income (Latest Year)
Revenue$78.18M
Gross Profit$17.24M
EBITDA$-40.28M
Operating Income$-53.99M
Net Income$-49.03M
EPS$-1.15
EPS Diluted$-1.15
Shares Outstanding$42.52M
Balance Sheet (Latest Year)
Total Assets$344.68M
Current Assets$122.15M
Cash & ST Investments$30.42M
Total Liabilities$85.25M
Total Debt$15.38M
Net Debt$-670K
Total Equity$259.44M
Debt / Equity0.06
Valuation Ratios
P/E Ratio-0.9
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message